EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Body mass index and weight changes in patients with HER2-positive early breast cancer: A sub-analysis of the APHINITY trial

Chiara Dauccia, Maria Alice Franzoi, Samuel Martel, Dominique Agbor-Tarh, Shona Fielding, Martine Piccart, Jose Bines, Sibylle Loibl, Serena Di Cosimo, Ines Vaz-Luis, Antonio Di Meglio, Lucia Del Mastro und 9 weitere

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2025.115489 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Chiara Dauccia und 20 weiteren Autor:innen. Beteiligte Einrichtung: Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Rue Meylemeersch 90, Bruxelles 1070, Belgium;…. Hauptthemen laut MEDLINE: Breast Neoplasms, Body Mass Index, Erb-b2 Receptor Tyrosine Kinases, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsBody Mass IndexErb-b2 Receptor Tyrosine KinasesAntineoplastic Combined Chemotherapy ProtocolsObesityHumansFemaleMiddle AgedAdultAgedOverweightThinnessChemotherapy, AdjuvantTrastuzumabPrognosisDisease-Free Survival

Stichwörter der Autor:innen

Body mass indexEarly breast cancerHER2-positiveObesityOverweight

Substanzen

Erb-b2 Receptor Tyrosine KinasesTrastuzumabERBB2 protein, human

Autor:innen und Institutionen

  • Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Rue Meylemeersch 90, Bruxelles 1070, Belgium; Department of Internal Medicine and Medical Therapy, University of Pa…
  • Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Rue Meylemeersch 90, Bruxelles 1070, Belgium.
  • Hôpital Charles-Le Moyne, Internal Medicine Department, Université de Sherbrooke, Quebec, Canada.
  • Frontier Science Scotland, Kincraig, Scotland, UK.
  • Instituto Nacional do Cancer, Rio de Janeiro, Brazil.
  • German Breast Group c/o GBG Forschungs GmbH; Goethe University, Frankfurt, Germany.

Zitieren

APA

Dauccia, C., Alice Franzoi, M., Martel, S., Agbor-Tarh, D., Fielding, S., Piccart, M., Bines, J., Loibl, S., Di Cosimo, S., Vaz-Luis, I., Di Meglio, A., Del Mastro, L., Gombos, A., Desmedt, C., Jerusalem, G., Reaby, L., Pienkowski, T., Lambertini, M., Agostinetto, E., …, & APHINITY Steering Committee and Investigators (2025). Body mass index and weight changes in patients with HER2-positive early breast cancer: A sub-analysis of the APHINITY trial. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115489

Vancouver

Dauccia C, Alice Franzoi M, Martel S, Agbor-Tarh D, Fielding S, Piccart M, et al. Body mass index and weight changes in patients with HER2-positive early breast cancer: A sub-analysis of the APHINITY trial. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115489

BibTeX
@article{Dauccia2025,
  author = {Dauccia, Chiara and Alice Franzoi, Maria and Martel, Samuel and Agbor-Tarh, Dominique and Fielding, Shona and Piccart, Martine and Bines, Jose and Loibl, Sibylle and Di Cosimo, Serena and Vaz-Luis, Ines and Di Meglio, Antonio and Del Mastro, Lucia and Gombos, Andrea and Desmedt, Christine and Jerusalem, Guy and Reaby, Linda and Pienkowski, Tadeus and Lambertini, Matteo and Agostinetto, Elisa and Azambuja, Evandro de and APHINITY Steering Committee and Investigators, APHINITY Steering Committee and Investigators},
  title = {Body mass index and weight changes in patients with HER2-positive early breast cancer: A sub-analysis of the APHINITY trial},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2025.115489}
}
Kostenlos starten →